EXTRAWELL PHAR(00858): Yang Xiaorong appointed as an independent non-executive director.

date
21:34 20/01/2026
avatar
GMT Eight
Jingyou Pharmaceutical (00858) announced that Mr. Fang Linhu, who has been serving as an independent non-executive director since June 11, 2001, has resigned from the positions of independent non-executive director, chairman of the Company's Audit Committee and Remuneration Committee, as well as member of the Company's Nomination Committee, starting from January 20, 2026, due to his advanced age and the need to devote more time to family matters.
EXTRAWELL PHAR (00858) announced that Mr. Fang Linhu, who has been serving as an independent non-executive director since June 11, 2001, has resigned from his positions as independent non-executive director, chairman of the company's audit committee and remuneration committee, as well as a member of the nomination committee, starting from January 20, 2026, due to his advanced age and the need to focus more on family affairs. The Board of Directors further announced that Ms. Yang Xiaorong has been appointed as an independent non-executive director starting from January 20, 2026. Following the resignation and starting from January 20, 2026, the composition of the following board committees will change as follows: Audit Committee: Mr. Fang will no longer serve as chairman; Ms. Jin Song, the current independent non-executive director, has been appointed as the chairman; Ms. Yang has been appointed as a new member. Remuneration Committee: Mr. Fang will no longer serve as chairman; Ms. Jin Song has been appointed as the chairman; Ms. Yang has been appointed as a new member. Nomination Committee: Mr. Fang will no longer serve as a member; Ms. Yang has been appointed as a new member.